Balchem (BCPC) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Balchem in August 2026.
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Balchem's stock with a target price of $185.17, indicating growth potential.
Financial Health
Balchem Corp is showing strong revenue, cash flow, and profitability, indicating solid financial performance.
Dividend
Balchem Corp's dividend yield of 0.59% is below average, indicating modest returns for dividend investors. If you invested $1000 you would be paid $5.90 a year in dividends (based on the last 12 months).
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
